flrfi Reductien Act of 15395, :16 EISGIYS are
`
`F’T(‘Je‘AiA-"35: {(33-13)
`Approved for use ihinugh (]'i!3‘!:’?D't-=§, Qioifi EiG5i—t‘.-{J32
`LLS. F’-ateni and Trziderrzazir. Office, E19. iI}EF‘ARiTMEN‘T DF DCEMMEWZIE
`mired in zesptmd is miiedim of intiimntkra §.Ei']§E.‘S.‘S it 113
`I‘
`_ a vatid OMB ctzmmt num‘i_1eI
`
`TRARSMET-{AL
`(ONLY FUR NEVI’ N{3NP:QE3i7“i3?UN.4i_ .4PPl.iC.4T:'0N-9 UNDER
`3? W rmrazt
`
`E
`
`.F'i§i",€iF?}E-“_‘r" E-*()CkE3i Ni}.
`Flajiv R. Singh
`First Named ;‘.rrsre.",-fox’
`COMPQSiTiQN:S CON3TA.iNii\iG Fi‘_UC5RiNE
`SUBSTITUTED QLEFINS AND METHODS AND
`SYSTEMS USSNG SAME
`53<presS ;'t«i.~3s'i i_siJeJ No.
`
`APPLICATNDN ELEMENTS
`See MPEP -:‘§Ia;‘_\fE'r' Silt? ourvcvalnirrg £Jf?i!T}' pate. t .2§zs.u.?iL=3§f:.1-‘I £‘tJm‘:?m’5.
`
`1
`
`'
`
`2
`
`Fee Transmittal‘ Form
`{F'T0z'SB’1T or equivaterrt}
`See 3?’ CFR L2?
`Appiieant asserts smaii entity status.
`
`3 El Applicant certifies micra entity status. See 3? CFR 1,29,
`'
`Angsticeni must atia-:‘*1 form Pi'0.’SB4'§5A ca’ 8 or equivaient.
`4.
`Specifil-eaiion
`37
`{mar Pages
`Both the claims and abstract must start on a new cage.
`{See MPEP § &'}.9_L11:'a#x§::‘;.'r-‘r;.‘12rzetis3.'r an the :\.‘ein.:re'd a.'.'angerner
`
`1
`
`}
`gram: sears
`|:| Drawingisi gas u.s_+:. 113;
`i
`2
`{Tami Pages
`in:ve~mor's Oath or Deciaralion
`5.
`-_Y)Ir3(:li.<(:‘.“:';<._'.< suhxséihtke siaimms 1.-1-Ids! 3.7 CF}? 1?. E14 arid assignments sewing as an
`oafhorcfiz-daietivm
`3.? CFF‘ $.61’-{:2-j_3
`
`9-
`
`El Nevuw exemjtevj {curiginai cur copy)
`A copy from a prior appticaiion (3? CFR 'U33(d}}
`Appiicafion Data Sheet ’.See n-me befow.
`37 £1??? 1 5'6 {PTL'3i»5.t»3J'i¢ or eqtaiacaiem}
`CD-RUM or CB—F-i
`in duplicate, large table. or Canwpuier Program {.1-‘c§;t;e;:::i-‘hr;
`
`|:| Landscape Tabie on CD
`Nucieotide andfor Amino Acid Sequence Submission
`{if appiirabiel items a — c, are seqamired}
`
`:1 El Computer Readahte Farm {CREE
`Ev.
`Specificalian Sequence Lisimg an:
`
`ADDRESS TO.’
`
`Commissioner for Patents
`1'-‘.0. Box 1:350
`Aiexandria, VA 22313-1450
`ACCGMPANYENG APPLSCATKDN PARTS
`
`‘E0. |:| Assignment Papers
`(cover sheei 8: dcn:ument{s}}
`
`Name of Assigrxee
`
`‘M.
`
`37 cm 3.73m Statement
`|:| Paw“ of Anomay
`{wfrsn there is an assgneej
`12 El English Translation Document (ifa,:y-J}:-:at.~Ie)
`H
`infzzrrnatien Disclosure Statement
`_
`t'PTQ.‘"SB?O3 or t3TC}-T449}
`Copies of cibatictns attached
`Preliminary Amendment
`
`‘i4.
`
`15" El Return Receipt Postcarfi
`{!’v‘.5‘EP § 5&3} {S-!vom‘L'.* he s;e<..\‘§c.i:‘i';‘-' iienvizedi
`
`15
`
`fir
`
`'
`
`13.
`
`Certified Copy of Priarity Documentfis}
`(if f{:~re¢'grz pvionfiy 5.5‘ ciairne-(F)
`Nunpubiication Request
`umier 35 U C :22 cs)(2}(B;{g Apgoiicam must mam tum: erozsatza gr
`equwaienl
`
`Other.
`
`TRACK 3 REQUEST FORM
`
`is. El Paper
`3. El SERUM or €3D—R {2 copies); or
`cs '3 Stsuteinents venfying identitgvaf above copies
`{3} Benefit ciaims under 3?‘ CFR 1 3'8 and foreign priority ctaims under 155 must be induded in an Appiication E1313 Si'aEei(AlZ1S].
`"Make:
`{2} Far appmatims flied under 35 U.S.C_ M ‘L the appiicatim must cmtain an ADS specifying the appiicant ifthe amzdicant is an
`assignee; person to whom the inventor is under an obiigali-an ta assign, or persccn who amenvise shows sufficient proprietary
`interest in the matter.
`3? CFR 't .4533}.
`13. CORRESPONDENCE ADDRESS
`
`The address a5s::x:iate{t with Customer Number".
`
`91‘ 9?G
`
`95' El 90"“-"5"5W“5‘3“m ‘'-“5d‘e35 9939“
`
`
`
`——:
`—‘—
`:’Kenneti'z Ma 53,3322»;
`March 25, 2914
`,
`‘
`Kenneth Ma
`53.339
`
`Registratirsri No.
`§Am,,.eWem)
`
`Name
`
`;—\CTIVE .'£‘_".2l2969’i=3. O?~.~'L.,.~
`
`Arkema Exhibit 1045
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`.
`.
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`The application data sheet is part of the provisional or nonprovisional application for which it is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`
`D Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuant to
`37 CFR 5.2 (Paper filers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`Inventor Information:
`
`Inventor
`Legal Name
`
`1
`
`‘
`
`Prefix Given Name
`Middle Name
`Family Name
`_2
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`StateIProvince
`NY
`country of Residencei ‘ US
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`18 Foxfire Drive
`
`City
`
`Getzville
`
`StateI'Province
`
`NY
`
`Inventor
`
`2
`
`Legal Name
`
`Midd'°"ame
`
`Fam"v"ame
`
`Residence Information (Select One)
`
`(9 US Residency 0 Non US Residency 0 Active US Military Service
`
`StatelPr0VinCe
`
`Country of Residence i
`
`Mailing Address of Inventor:
`
`136 Larkspur Lane
`
`Amherst
`
`| 14228
`
`| StateIProvince
`| Country i
`| US
`
`| NY
`
`Address 1
`Address2
`
`City
`Postal Code
`Inventor
`3
`Legal Name
`
`Given Name
`Ian
`
`Middle Name
`
`Family Name
`Shankland
`
`Residence Information (Select One) @ US Residency 0 Non US Residency 0 Active US Military Service
`
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`_
`_
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`HOOO3965DIV1E
`
`.
`.
`Title of Invention
`
`City
`
`Buffalo
`
`StateIProvince INY lcountry offiesidencel
`
`US
`
`Mailing Address of Inventor:
`
`Addfe55 1
`
`Address 2
`
`6 Horizon Court
`
`Buffalo
`
`I StateIProvince
`City
`I Country i
`I US
`I 07869
`Postal Code
`Inventor Information blocks may be
`All
`Inventors Must Be Listed — Additional
`generated within this form by selecting the Add button.
`
`| NY
`
`Correspondence Information:
`
`Enter either Customer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`D An Address is being provided for the correspondence Information of this application.
`
`Customer Number
`
`Email Address
`
`Add Email
`
`Application Information:
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND
`SYSTEMS USING SAME
`
`Title of the Invention
`
`Attorney Docket Number HOOO3965DIV1E
`
`Small Entity Status Claimed
`
`|:|
`
`Application Type
`
`Nonprovisional
`
`Subject Matter
`
`Utility
`
`Total Number of Drawing Sheets (if any)
`
`Suggested Figure for Publication (if any)
`
`Filing By Reference:
`
`Only complete this section when filing an application by reference under 35 U.S.C. 111(c) and 37 CFR1.57(a). Do not complete this section if
`application papers including a specification and any drawings are being filed. Any domestic benefit orforeign priority information must be
`provided in the appropriate section(s) below (i.e., ”Domestic Benefit/National Stage |nformation" and "Foreign Priority Information”).
`
`For the purposes of a filing date under 37 CFR1.53(b), the description and any drawings of the present application are replaced by this
`reference to the previously filed application, subject to conditions and requirements of 37 CFR1.57(a).
`
`Application number of the previously
`filed application
`
`Filing date (YYYY-MM-DD)
`
`Intellectual Property Authority or Country i
`
`Publication Information:
`
`Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`Request N01: ‘I20 Publish. I hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen months after filing.
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 0173172014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`HOOO3965DIV1E
`
`.
`.
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a power of attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Number will be used for the Representative Information during processing.
`
`Please Select One:
`Customer Number
`
`@ Customer Number
`
`0 US Patent Practitioner 0 Limited Recognition (37 CFR 11.9)
`
`Domestic BenefitlNationa| Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C.119(e),120,121, or 365(c) or indicate National Stage
`entry from a PCT application. Providing this information in the application data sheet constitutes the specific reference required
`by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`When referring to the current application, please leave the application number blank.
`
`Prior Application Status
`
`Pending
`
`Application Number
`
`Continuity Type
`Division of
`
`Prior Application Number
`13844206
`
`Filing Date (YYYY-MM-DD)
`2013-03-15
`
`Prior Application Status
`
`Pending
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`Prior Application Status
`Application
`Number
`11847192
`
`Patented
`.
`.
`Continuity Type
`
`Prior Application Status
`
`Expired
`
`Prior Application
`Number
`10837525
`
`Filing Date
`(YYYY_MM_DD)
`2004-04-29
`
`Patent Number
`7279451
`
`|5SUe Date
`(YYYY_MM_DD)
`2007-10-09
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`10694273
`
`Claims benefit of provisional
`
`60421263
`
`2002-10-25
`
`Prior Application Status
`Application Number
`
`Expired
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD)
`
`10694273
`
`Claims benefit of provisional
`
`60421435
`
`2002-10-25
`
`Prior Application Status
`Application
`
`Patented
`.
`
`.
`
`Prior Application
`
`Filing Date
`
`|SSUe Date
`
`11847192
`
`Continuation in part of
`
`10694272
`
`2003-10-27
`
`7230146
`
`2007-06-12
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`EFS Web 2.2.11
`
`d
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Attorney Docket Number
`_
`_
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`H0O03965DIV1E
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`
`constitutes the claim for priority as required by 35 U_S_C_ 119(b) and 37 CFR 1_55(d)_ When priority is claimed to a foreign application
`that is eligible for retrieval under the priority document exchange program (PDX) ‘the information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1_55(h)(1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g)(1).
`
`Application Number
`
`Country i
`
`Filing Date (YYYY—MM—DD)
`
`Access Codei (if applicable)
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`D 16, 2013.
`NOTE: By providing this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`16, 2013, will be examined under the first inventor to file provisions of the AIA.
`
`Authorization to Permit Access:
`
`Authorization to Permit Access to the Instant Application by the Participating Offices
`
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 0113172014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`H0O03965DIV1E
`
`.
`.
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JPO), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any other intellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checked ifthe applicant
`does not wish the EPO, JPO, KIPO, WIPO, or other intellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have access to the instant patent application.
`
`In accordance with 37 CFR 1.14(h)(3), access will be provided to a copy ofthe instant patent application with respect
`to: 1) the instant patent application-as-filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)—(d) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has been filed in the instant patent application; and 3) any U.S. application-as-filed from which benefit is
`sought in the instant patent application.
`
`In accordance with 37 CFR 1.14(c), access may be provided to information concerning the date of filing this Authorization.
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`1
`Applicant
`lfthe applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and address of the legal representative who is the applicant under 37 CFR
`1.43; or the name and address of the assignee, person to whom the inventor is under an obligation to assign the invention, or person
`who otherwise shows sufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 (assignee, person to whom the inventor is obligated to assign, or person who otherwise shows sufficient
`proprietary interest) together with one or more joint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`0 Legal Representative under 35 U.S.C. 117
`
`0 Joint Inventor
`
`0 Person to whom the inventor is obligated to assign.
`
`0 Person who shows sufficient proprietary interest
`
`If applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Name of the Deceased or Legally incapacitated Inventor :
`
`If the Applicant is an Organization check here.
`
`Orgamzauon Name
`
`Honeywell International Inc.
`
`Mailing Address Information:
`Address 1
`101 Columbia Road
`
`Address 2
`
`City
`
`Country i US
`Phone Number
`
`EFS Web 2.2.11
`
`Morristown
`
`StateIProvince
`
`NJ
`
`Postal Code
`Fax Number
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`_
`_
`Application Data Sheet 37 CFR 1.76
`
`Attorney Docket Number
`
`H0O03965DIV1E
`
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`Emai'Address
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Add
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not subsitute for compliance with any requirement of part 3 of Title 37 of CFR to
`have an assignment recorded by the Office.
`
`Assignee
`
`1
`
`Complete this section if assignee information, including non—app|icant assignee information, is desired to be included on the patent
`application publication . An assignee-applicant identified in the "Applicant |nformation" section will appear on the patent application
`publication as an applicant. For an assignee—app|icant, oomplete this section only if identification as an assignee is also desired on the
`patent application publication.
`
`If the Assignee or Non—App|icant Assignee is an Organization check here.
`
`Given Name
`
`Middle Name
`
`Family Name
`
`Mailing Address Information For Assignee including Non-Applicant Assignee:
`
`Address 1
`
`Address 2
`
`City
`
`Country i
`
`Phone Number
`
`Email Address
`
`StateI'Province
`
`Postal Code
`
`Fax Number
`
`Additional Assignee or Non-Applicant Assignee Data may be generated within this form by
`selecting the Add button.
`
`Signature:
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`Date (YYYY-MM-DD)
`lKenneth Ma63,839/
`T Regisirafion Number
`
`2014-03-25
`63839
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`EFS Web 2.2.11
`
`

`
`PTOIAIAI14 (12-13)
`Approved for use through 01f31l2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number
`
`H0O03965DIV1E
`
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`Application Number
`COMPOSITIONS CONTAINING FLUORINE SUBSTITUTED OLEFINS AND METHODS AND SYSTEMS
`USING SAME
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount oftime you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.11
`
`

`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`(1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process andlor examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements ofthe Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 21B(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or hislher designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i_e_, GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuan
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.2.11
`
`

`
`IN THE I-WWTED STATES PATENT AND TRABEMARK OFFICE.
`
`Docket N0; HO0U39fi§ DIVIE
`
`{PATENT}
`
`111 re Patent Application of:
`Rajiv Rm Singh et 31.
`
`Appliazatitm New; Not Yet Assigned
`
`€.‘0nfir11'1ation N0; N./'A
`
`Fiied: C‘.011cu11'e1;t.13= Herewith
`
`..i\.1‘tU11it:
`
`F01‘? COE\=IP{}SI.TI{}N'S {?()NTAININ€} FLUORIN-E.
`SUBSTITUTED OLEFENS AND METHODS
`AND SYSTE_Ԥv'IS SING SAME
`
`Examiner: Not Yet Assigned
`
`FIRST PRELI=_\~'IE.‘€ARX" .-*-L‘rIE..%."x’DReIEP'iT UNDER 37 C.F.R. 1.115
`
`Cfunu11issim;e1' for P3 tents
`
`PO. Box 1450
`
`Alexandria, ‘V14. 22313-1-«='15'£)
`
`Dem“ Madam:
`
`INTRODUCITORY C_?OME\\iENTS
`
`Prior to ex&mi11atis3n an the merits, please amenci the abm-*e.—idenfifie.d US. patent appiicatiuil as
`
`foiiows:
`
`Amendments to the Specification begin 011 page 2 of this pa~.pe1i.
`
`Anlendments tn the Clailns are raflected in the lismxg cf ciainia wliich be._gi11s an page §4 of this
`
`paper.
`
`Rema1'ks.r‘Argu111ents begin on page 19'.» of this paper.
`
`ACTIVE. 25213490171 D3<"‘36e"ZG 14 13:47 ;~L\«iC fl"
`
`’
`
`

`
`Appiicaticm N0. N0: Ya Agsigxed
`First P2'eh’min3ry A1”i).EIid1'i}fiIii’
`
`5
`
`[Jacket
`
`: HGOi)39f§5{)I\-“'213E
`
`TO THE SPECIIFICATION
`
`Please 1’ep1a.ce11‘1e cmrent spec.i'fica.rio11 Witt} the Sltlbstitme Specificaiion. Marked up copies
`
`uf the Substiimle Specificalioil. as well as a.s':.1e2mc0py csf the Stibsiittlte Specification, are stlbnlined
`
`co'ncu1‘1'e11t1y 11e1‘ewith. No new n1afi,er is asidszd.
`
`ACTTIVE 352.1321‘,-)0‘.-'1 D3«"‘36e"ZG}4 19:4-7 A;\-ii; '_ ,'_
`
`

`
`Appiicaticm N0. N0: Ya Agsigxed
`First P2'eh’min3ry A1”i).EIid1'i}fiIii’
`
`:_
`
`[Jacket
`
`: HGOi)39f§5DI\-“'213E
`
`ARIENDMENTS TO THE CLAl3\\'i.S
`
`3. — Bi}. {Canceled}
`
`21“ (New)
`
`A xxxeiihmi f0rpmd3uci11g an ammilabile air cuilditiolljn sysiein for use wiih
`
`2,
`
`3, 3-’zet1‘aflm1'op1'Upe11e{EH30-1234}:£} cc_m1p11':a1'ng:.
`
`{a} prm-“iding an ailmillobile V-'£1.p01” s:.mnp1'ession air C1011€HYi01)iDg systexn usable with
`
`1‘ef1‘igera11£ L1,1,2.—tei1’afl11o1'oeTha11e {HFC-134a) and hat-‘ing at" least one compressor and at
`
`least one condenser; and
`
`{I3} p1'0\ricIi11g a heatt1'a11sfe1' cnm}.m.<_:ition in said systexn, .<_:a1'dheatf1‘a11sfer composition
`
`ceiisisting essentialiy of:
`
`{i} at least about 5(3% by weight of 3 1‘ef1'ige1'31'1tcm1sisIing esseutiaily Qf HFQ—
`
`1234yf ; and
`
`{ii} Z11bric.antc0nsisting essemially of }J'Ol}-‘aH&'j«'lB11~E5 gijgcohfs»), and
`
`whB1‘e.in (1) said c011dense1' is nperable with said 1'efrigera11r in a tmilperature range T1131‘
`
`imzludes ISOQF and :13) said system when operatillg at .3 condensel‘ te111pe1‘a.tu1‘e of 159°?
`
`achieves a ca.pacity 1‘e}ative to HEC—’i34a. of about 1 and a Coefficient 0fPe1‘fom1a11ce (COP)
`
`relative in HFC-13%;: of about 1.
`
`22.. {New}
`
`The method of claim 21 wherein said i11bric.:1nt is present in the heat. traxxsfer
`
`003190516011 in an amount of fronl about 3(}% to about 5{}% by weight.
`
`23.. (New)
`
`The method of cfiaim 21 whale-ii) said HFO-1234}-“f is presem in the heat
`
`tflilléfei‘ c:on1p05iti011in an amount of at least about ?I.)% by weight.
`
`24% {New}
`
`The nlethod of c-Eaim 21 wherein said1<ef1'ige1'anth;as nu substzxlltial acute
`
`to:<icit3-= as 111ea.<_:u1'ed by inhalation exposure To mice and rats.
`
`ACTIVE. 252 l3:190‘Ul E53<"‘36e"2U 14 16:47 Alxit -‘, '_ I
`
`

`
`Appiieaticm Ne. N0: Yefi Agsigxed
`First P2'eh’min3ry Ametidmetd
`
`"
`
`Becket
`
`: HGOi)39f§5{)I\-“'213E
`
`(New)
`
`The method of c:-Eaim 2-A-1 whe1'ei'n said ref1'ige1‘£mt11as 3 GEnba§_Wa1111'u1g
`
`Pmientiai (CirW"P) of not g1‘e3fe1‘t}13n3bm1t ESQ“
`
`26. (New)
`
`A method of eollditmning the air in an automobike 'usi11g an automobiie air
`
`heon(1iU'nmng 53-‘stair: including at lea st {me heo1npres.sm‘_._ at Eeast ene cendenser and at Beast
`
`one evaporatol‘, said method eonipxisixlgz
`
`{3} utiiizing in said 55-=st.e111 a.11e.:n'. ‘transfer eolrnpositioil eonsistmg esseiltiaiiy of:
`
`(i) at least about 5895-‘b by weight 053. 1‘efrige1'm'1t emlsisting essentialiy Df
`
`3, 3: 3-
`
`tet1'afluQ1'0p1'0pene {HFO-1 2'3‘-'1}-'3}; and
`
`{ii} h1b1‘ic.ant consistmg essentially of p»0E}71ky1e11e gig.-‘<3-01(5)V; and
`
`(b) rerliovmg heat fmm said HFO-i234yfb§«' condelxsing said1‘efiige1’e11¥ in said condenser
`
`when said condenser is operatixxg over a tem_pe1':m.11‘e range that that mehldes about 15G“F.
`
`27. {New}
`
`The nmfhed of eiaml 26 wherein said refrigerant achieves in said syste1I1 ad
`
`heapacify relatixie in HF{‘.—} 343 Of about 1 and a {iuefficiem {ref Pe1‘fo1‘1nance {COP} fehltive to
`
`HFC—}34a of about 1.
`
`28. {New}
`
`The method of claim 36 wherein said hlbxicant is present in the heat t1'a:n.sfe1’
`
`cemposiiion in an amonxxt of frorn aboui 30% to about 50% by weight.
`
`29. {New}
`
`The method of ekainl 27 wherein said HFCLI 23«1yf is present in the heat
`
`tmlsfer c0mp0siti011in an amount of at least about ?l.)% by weight.
`
`30% {New}
`
`The method of c:-Ea£n1 29 wherein said 1<efi'ige1'ant has no stibstaluial acute
`
`toriicity as mea.<_:ured by inllalation eyiposure to mice and rats.
`
`31. {New}
`
`The method of eiaixn 30 whe1'ei11 said refrigeralu has a.GEObaiWan11iug
`
`Potential (GWP) of not greater than about 150%
`
`ACTIVE. 252 l3:190‘Ul E53<"‘36e"2U 14 16:47 Ahsii -‘, '_ I
`
`

`
`Appiieaticm N0. N0: Yefi Agsigxed
`First P2'eh’min3ry A1”i).EIid1'i}fiIii’
`
`,_
`
`[Jacket
`
`: HGOi)39f§5DI\-“'213E
`
`3;’; (New)
`
`A heat i1':«msfe1' c0mpc«.<_zirion for use in an a11t0mnhi1e air Cfllldiiigflllillg system
`
`of the type 31a.\»‘i11g 3 e0nde11se:1' opeiaiixig in a iei11per3.iuIe Hiflgfi that inchldes about 1§O““F;
`
`said heat ‘t£a11sfe-1‘ ::0.n1po:siti011 cQn5isti11g esseiltiaiiy of:
`
`{i} at ieast about 5I(}% by weight of 3 1"ef1“ige1'a11t c:eU11sisting essexifiailjf Uf
`
`3, 3, 3-
`
`f.etrz:flum'op1‘ope11e (HFO-12343-'1'}; and
`
`{ii} hlblicaznt consistixlg ee-sseniialiy c»fp01}lI:1k};lene g1}-'euI{s)V_.
`
`whereein s3id1'efi'ige1‘ant under the CGl}diTi011S cf said -:u1:dense1‘0pe1'ating at abet}?
`
`.15€3°F in said automobile air c011din'e11ing system has
`
`C':1pi'i<I'.iI‘§' 1'eIative to HF{j?-134-£:ef
`
`about 1 and a Ceefficiem ofPeI‘f01“manee: (COP) reietive to EEFC-1343 ofabuuf 1,
`
`33. {New}
`
`The heat transfer e0111pcssiiioI1 0f::Ia:in1
`
`wherem said 1'1ea.tt1‘ansfe1‘
`
`eompositiolx has me liquid phase mrer the tempe1‘a!m‘e fiillgfi of fimn about --30°C to ai3m_:t
`
`+5(}“‘C.
`
`34. {New}
`
`The heat transfer C-0n1p0SiIiD11 ufciahn 32 wherein said lubricant is p1<ese11{i31
`
`fhe heat£1':msie1'e0I11p0siti011 in an amomli of from ahoui 30% to about 50% by weight.
`
`35. {New}
`
`The heat transfer composition of ciaim 32 wherein said HFO—1234yfis
`
`present in the heat, t1‘ansi3e1' composition in an ammmt of at least abet}? F0‘?--"E: by weight.
`
`36 {New}
`
`The hear i'i'311Sf€Y eompsssitielx of c-.}ain1 35 w11erein said 1'ef1'1'gera11t has no
`
`substantia.ia.c11tee im(ie»it._\»= as ;11ea.su1'edb_\= inhalation exposure to mice and rats.
`
`3?. (New)
`
`The heatt1’aI1st7erc0I11p0siti0n ofeiaim 36 wherein said refrigerant has a
`
`Giobal Wam1i11g Poientiai {{}WP)e of not greetei‘ {ham about 150.
`
`38. (New)
`
`The heat t1‘ansfe1‘ eompositioll ufeiaim 37 wherein said1“ef1’ig,era11t czansists of
`
`HF‘O—1Z3='i;f.
`
`39. {New}
`
`A nlethod fo1'proVidi1'1g a system for cooling air in an autonlobile comprising:
`
`ACTIVE. 3SZl3:190‘Ul 03:‘
`
`3014 16:47 AI\:iC-‘,'_ I
`
`

`
`Appiicaticm N0. N0: Ya Agsigxed
`First P2'eh’min3ry A1”i).EIid1'i}fiIii’
`
`I
`
`[Jacket
`
`: HGOi)39f§5DI\-“'213E
`
`{a} p1'o\ridi11gi11 the m.1tou10'biie. a vapor cmnpressioix. air co11ciiti.uni11g Sj«'S{‘€§)1hI3ViI}g at least
`
`one L'OIl1pI'BSSO1‘ and m.1east.m1e condenser: ‘and
`
`{I3} p1‘ovic[ing_ in said S3«’Sh:1'D a heat‘t1'a11sib1‘c0111p0siti0+n cm1sis¥:i11g. es:sem'.ia1i3=‘ of:
`
`(1) at least abmlt fifié?-'5 by weight‘ ofa refiigerant consisfirlg essentiaiiy of 2., 3, 3, 3-
`
`tet1“3fl1101'op1‘0pe11e(fHFO—1234yf); and
`
`{ii»}h1b1'1'cantconsistixlg esseiitialky of polyalicyleila g1§:co1{’s)5 and
`
`wherein (1) said c-»ondense1‘is operable with said 1’e.fi’i.gr:.1‘a*13t in a tempe.n‘mu‘e range that
`
`includes 150°}? and (2) said S}='Sf€Ii‘i nperatiilg at a cc:1'1de11se1' te1np:':1’atu1‘e of 130’? achieves a,
`
`C3pa.CiTff 1<e1aIi\=‘e to HFC-1343 Qf abom '1 and a Coeffiszient 0f Pe1'f0m1an<:e {COP} 1’el3ti\-‘B to
`
`Hf(.‘f—}34a of abnut 1.
`
`:10. {New}
`
`The method of ciaixn 39 whereiil (A) 3ai¢i1'e-frigeralxt has 11:: substantial acute
`
`toxicity as measured by inhalation szxpostire to mice a11dn':ts; (B) has a {E20113} Warming
`
`Petelltiai {GWP} of not g1‘eate1' than about 150', and (C?) said HFO-"123 dyf is present in the
`
`he3ITl‘3}1SfEI’ C01IlpOSiIiO11 in an zunount of at least abnm ?G% by weight.
`
`ACTI'\»"E 352.1321‘,-)0‘.-'1 D3«"‘36e"ZG}4 13:4-7 A;\-iC'_